A detailed history of Aspect Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Aspect Partners, LLC holds 20 shares of OGN stock, worth $291. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$291
Previous $414,000 7.49%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$10.95 - $17.32 $219 - $346
20 New
20 $288,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Aspect Partners, LLC Portfolio

Follow Aspect Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspect Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspect Partners, LLC with notifications on news.